Emergent Biosolutions EBS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's invested capital?
- Emergent Biosolutions (EBS) reported invested capital of $946.2M in Q1 2026.
- How has Emergent Biosolutions's invested capital changed year-over-year?
- Emergent Biosolutions's invested capital decreased by 11.8% year-over-year, from $1.07B to $946.2M.
- What is the long-term trend for Emergent Biosolutions's invested capital?
- Over 5 years (2020 to 2025), Emergent Biosolutions's invested capital has grown at a -12.4% compound annual growth rate (CAGR), from $1.74B to $897.2M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).